Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
REPL - ACCOUNTS PAYABLE
Accounts Payable REPL - Replimune Group, Inc.
2.58 M
LAST VALUE
-16.89%
2 YEAR CAGR
-18.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR